Frazier Lifesciences Acquisition Corp

Overview

• IndustryBlank Checks¹
• HeadquartersSeattle, Washington¹
• Incorporated inCayman Islands³
• Business addressTwo Union Square, 601 Union Street, Suite 3200, Seattle, Wa 98101³
• Filer category, Emerging growth company³

See how the biggest companies compare on our leaderboards

Corporate structure

Frazier Lifesciences Acquisition Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Frazier Lifesciences Acquisition Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Leadership

Who has led Frazier Lifesciences Acquisition Corp, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerJames N. Topper Dec 8, 2020 to Dec 17, 2020⁷
• Chief financial officerDavid Joseph Topper Dec 8, 2020 to Nov 23, 2022⁸

Timeline

1. Nov 23, 20228-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale¹⁵
2. Nov 15, 20228-K Shareholder vote; Regulation FD disclosure¹⁶
3. Jul 25, 20228-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure¹⁷
4. Jul 25, 20228-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure¹⁸
5. Jan 26, 20228-K Earlier financial statements no longer reliable¹⁹
6. Dec 8, 2020New chief executive James N. Topper becomes CEO⁷

Filings

42 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 5 major events, 9 insider forms, 11 large holders, 10 other. The latest 20:

1. Feb 14, 2023SC 13G/A EDGAR
2. Dec 2, 202215-12G EDGAR
3. Dec 1, 2022SC 13G/A EDGAR
4. Nov 25, 2022SC 13D/A EDGAR
5. Nov 25, 20224 EDGAR
6. Nov 23, 20228-K EDGAR
7. Nov 23, 2022SC 13D/A EDGAR
8. Nov 23, 20224 FORM 4 SUBMISSION EDGAR
9. Nov 23, 20224 FORM 4 SUBMISSION EDGAR
10. Nov 23, 20224 FORM 4 SUBMISSION EDGAR
11. Nov 23, 20224 FORM 4 SUBMISSION EDGAR
12. Nov 23, 20224 FORM 4 SUBMISSION EDGAR
13. Nov 15, 20228-K EDGAR
14. Nov 14, 20223 EDGAR
15. Nov 14, 2022SC 13G EDGAR
16. Nov 9, 202210-Q EDGAR
17. Nov 4, 20224 EDGAR
18. Nov 4, 20223 EDGAR
19. Nov 3, 2022SC 13D EDGAR
20. Nov 2, 2022SC 13G EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Alyeska Investment Group, L.P.SC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023²⁰
• James E. FlynnSC 13G/A, 2 filings Nov 14, 2022 to Dec 1, 2022²¹
• VIKING GLOBAL INVESTORS LPSC 13D/A, 3 filings Nov 2, 2022 to Nov 25, 2022²²
• Frazier Lifesciences Sponsor LLCSC 13D/A, 2 filings Sep 20, 2022 to Nov 23, 2022²³
• CITADEL ADVISORS LLCSC 13G/A, 1 filing Feb 14, 2022²⁴
• RA CAPITAL MANAGEMENT, L.P.SC 13G/A, 1 filing Feb 14, 2022²⁵

SEC filer profile

How Frazier Lifesciences Acquisition Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARFrazier Lifesciences Acquisition Corp¹
• CIK0001828326
• Filer status<br>emerging growth company¹
• Incorporated inCayman Islands¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)6770 Blank Checks¹
• Business addressTwo Union Square, 601 Union Street, Suite 3200, Seattle, WA 98101¹
• Phone617-570-8364¹
• Public float$143.7B as of Jun 30, 2021²
• On EDGAR sinceOct 15, 2020¹
• Filings108 in all: 425 (31), 3 (10), 4 (8), 8-K (8), 10-Q (6), 3/A (6), SC 13G (5), CORRESP (4)¹
  All 27 form types

  SC 13G/A (4), 25-NSE (3), SC 13D/A (3), 10-K (2), 10-K/A (2), SC 13D (2), UPLOAD (2), 10-Q/A (1), 15-12G (1), 424B4 (1), 8-A12B (1), 8-K/A (1), CERT (1), DEFM14A (1), DRS (1), EFFECT (1), NT 10-Q (1), S-1 (1), S-1MEF (1)

• Latest filingsAnnual report (10-K) Mar 25, 2022
  Quarterly report (10-Q) Nov 9, 2022
  Latest 8-K (8-K) Nov 23, 2022